Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Not pending/lapsed |
21 | DE file number | DAKZ | 603 42 558.5 |
96 | EP file number | EAKZ | 10 01 0584.0 |
97 | EP publication number | EPN | 2287288 |
54 | Designation/title | TI | Tierproteinfreies Zellkulturmedium |
51 | IPC main class | ICM (ICMV) | C12N 5/00 (2006.01) |
51 | IPC secondary class(es) | ICS (ICSV) | C12N 5/10 (2006.01), C12N 7/00 (2006.01), C12P 21/00 (2006.01), C12N 5/07 (2010.01) |
22 | DE application date | DAT | Jul 8, 2003 |
96 | EP application date | EAT | Jul 8, 2003 |
43 | Date of first publication | OT | Feb 23, 2011 |
| Date of publication of grant | PET | Nov 7, 2012 |
71/73 | Applicant/owner | INH | Takeda Pharmaceutical Company Limited, Osaka-shi, Osaka, JP |
72 | Inventor | IN | Mundt, Wolfgang, 1080 Vienna, AT; Reiter, Manfred, 1150 Vienna, AT; Grillberger, Leopold, Dr., 1220 Vienna, AT; Kraus, Barbara, 2120 Obersdorf, AT |
74 | Representative | VTR | HOFFMANN - EITLE Patent- und Rechtsanwälte PartmbB, 81925 München, DE |
| Address for service | | HOFFMANN - EITLE Patent- und Rechtsanwälte PartmbB, 81925 München, DE |
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 394243 P Jul 9, 2002
|
| Patent division in charge | | 44 |
97 | EP language of publication | ELANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LI, LU, MC, NL, PT, RO, SE, SI, SK, TR |
| Published EP/WO documents | EPWOPN | Original document:
EP000002287288 Searchable text:
EP000002287288 Original document:
EP000002287288B1 Searchable text:
EP000002287288B1 |
43 | Date of first publication | EVT | Feb 23, 2011 |
| Date of the first transfer into DPMAregister | EREGT | May 27, 2011 |
| Date of the (most recent) update in DPMAregister | REGT | Aug 31, 2023 (Show all update days)(Hide all update days)- May 27, 2011
- Date of the first transfer into DPMAregister
|
View procedures New applicant/owner details (No.: 7)INID | Criterion | Field | Content
Close details
|
---|
| Type of procedure | VART | New applicant/owner details |
| Legal/procedural status | VST | New applicant/owner details |
| Date of legal/procedural status | VSTT | Feb 16, 2016 |
| Issue number | HN | 12 |
| Year | PJ | 2016 |
| Publication date | VT | Mar 24, 2016 |
| Type of publication | PART | Bibliographic data |
| Part | HT | Part 3 |
71/73 | Applicant/owner | INH | Baxalta GmbH, Glattpark, Opfikon, CH; Baxalta Incorporated, Bannockburn, Ill., US |
71/73 | Previous applicant/owner | INHF | Baxter Healthcare S.A., Glattpark, CH, Baxter International Inc., Deerfield, Ill., US |
View procedures New applicant/owner details (No.: 8)INID | Criterion | Field | Content
Close details
|
---|
| Type of procedure | VART | New applicant/owner details |
| Legal/procedural status | VST | New applicant/owner details |
| Date of legal/procedural status | VSTT | Jun 4, 2021 |
| Issue number | HN | 28 |
| Year | PJ | 2021 |
| Publication date | VT | Jul 15, 2021 |
| Type of publication | PART | Bibliographic data |
| Part | HT | Part 3 |
71/73 | Applicant/owner | INH | Takeda Pharmaceutical Co. Ltd., Osaka, JP |
71/73 | Previous applicant/owner | INHF | Baxalta GmbH, Glattpark, Opfikon, CH, Baxalta Incorporated, Bannockburn, Ill., US |
| Date of update of the procedure | REGT | Jun 29, 2021 |